Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
14:03

Houston Methodist

Renal Amyloidosis

FEATURING Juan Gonzalez
  • 361 views
  • April 19, 2024
  • 4
12:27

Fernando Gomez-Peralta

ATTD 2022 Efficacy of the Insulin Pen Smart Cap Insulclock in People with Non-Controlled Type 1 Diabetes Mellitus (T1DM): A Multicenter, Randomized Clinical Trial

  • 82 views
  • May 11, 2022
  • 1
25:28

Complex Coronary Cases

A Link Between the Heart and the Brain: New Data on the Elderly

FEATURING Valentin Fuster
  • 591 views
  • August 31, 2023
  • 6
48:22

Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2D Medications

FEATURING Barbara Hirsch
  • 2,398 views
  • June 4, 2024
  • 4
29:35

Scripps Health

Eat Right, but Which Type? Diabetes and Diet

FEATURING Alex Bonnecaze
  • 898 views
  • January 14, 2022
  • 8
67:57

APP2APP Virtual Lectures, Inc

Obesity: A Disease of Abnormal Physiology - GLP1-RA, the New Molecule on the Block!

FEATURING Martine Altieri
  • 595 views
  • June 17, 2024
  • 6
19:52

M. Boulton

Diabetic Foot Update

  • 1,152 views
  • March 22, 2024
  • 9
40:47

Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Diabetes Management in Patients with Cardiovascular Disease and Heart Failure

FEATURING Daniel Einhorn
  • 914 views
  • May 14, 2019
  • 8
10:09

American Heart & Vascular Institute

Heart Failure With Reduced Ejection Fraction: New Therapies on the Horizon

FEATURING Nasrien Ibrahim
  • 1,164 views
  • September 16, 2021
  • 9
08:35

Scottsdale Interventional Forum 2017

Diabetes and Coronary Disease

  • 265 views
  • June 1, 2017
  • 3
13:21

The North American Thrombosis Forum (NATF)

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use Empagliflozin, Dapagliflozin and Antiarrhythmic Drugs? What Are the Guidelines for Patients with AFib and Elective PCI or ACS? When to Perform Catheter Ablation?

FEATURING Christian Ruff
  • 603 views
  • October 15, 2020
  • 6
09:51

St. Louis Shock & Heart Failure Symposium 2022

Heart Failure Therapy: Focus on Guidelines

FEATURING Justin Vader
  • 1,174 views
  • January 9, 2023
  • 9
28:22

3rd National Conference On Prevention Of Diabetes

Diabetes Prevention Program: Overview of Different Organizations

FEATURING Guillermo Umpierrez
  • 747 views
  • December 7, 2018
  • 6
39:59

NY Endovascular Summit

Outpatient Management of Diabetic Foot Infections

FEATURING Mark Kosinski
  • 266 views
  • November 25, 2022
  • 3
17:32

ECE 2023 Insights

ECE 2023 Insights: Obesity in Type 1 Diabetes

FEATURING Raquel Faradji
  • 266 views
  • July 10, 2023
  • 2
15:08

Cardiology Pulse 2019

Top 5 Cardiovascular Prevention Trials

FEATURING Robert Chilton
  • 267 views
  • October 30, 2019
  • 3
12:37

David Wheeler

2021 ADA Highlights: Landmark DAPA-CKD Trial in Kidney Disease: Extending the Benefits of SGLT2 Inhibitors to and Beyond Diabetic Neuropathy

  • 370 views
  • July 14, 2021
  • 4
30:03

37th Annual Advances in Heart Disease

Effect of Bariatric Surgery on Cardiovascular Outcomes: Can It Abrogate T2DM, Hypertension and Dyslipidemia and Reduce MACCE? Could the Surgery Improve Cardiac and Aortic Structure and Function?

FEATURING Michael Crawford
  • 268 views
  • February 19, 2021
  • 3
34:22

Georgia Heart Institute

Updates on the Cardiometabolic Therapies

FEATURING Jaime Burkle
  • 765 views
  • June 21, 2022
  • 7
17:56

Penn Medicine Heart and Vascular Center

How Do I Prescribe GLP-1 Agonists and to Whom?

FEATURING Jeremy Flood
  • 1,246 views
  • November 21, 2023
  • 9
24:25

Cardiometabolic Health Congress (CMHC)

Diabetic Kidney Disease Management: What Are the Strategies to Slow the Progression, and Effect of Finerenone on CKD Outcomes?

FEATURING Rajiv Agarwal
  • 766 views
  • December 28, 2020
  • 6
15:12

Penn Medicine Heart and Vascular Center

What Are the Metabolic Consequences of Insulin Resistance and What Is the Optimal LDL in These Patients?

FEATURING Daniel Soffer
  • 619 views
  • November 21, 2023
  • 6
09:24

Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Have We Learned From CVOTs in T2DM? Is MACE Independent of Glucose Lowering?

FEATURING Robert Eckel
  • 271 views
  • January 15, 2021
  • 3
72:15

Primary Care Education Consortium

Using CGM and the AGP for Clinical Decision-Making in Primary Care

FEATURING Stephen Brunton
  • 1,754 views
  • May 2, 2023
  • 8
30:23

The Texas Heart Institute

Update of Diabetes Treatment: Overview of Current Trials and ADA Practice Recommendations

FEATURING David Aguilar
  • 776 views
  • November 11, 2021
  • 6

Diabetes & CV Disease

All Topics: